Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endotheliumMASOOD, Rizwan; GUANGBIN XIA; SMITH, D. Lynne et al.Blood. 2005, Vol 105, Num 3, pp 1310-1318, issn 0006-4971, 9 p.Article

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphomaCOZEN, Wendy; GILL, Parkash S; SALAM, Muhammad T et al.Blood. 2004, Vol 103, Num 8, pp 3216-3221, issn 0006-4971, 6 p.Article

Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor GrowthKRASNOPEROV, Valery; RAM KUMAR, S; LEY, Eric et al.The American journal of pathology. 2010, Vol 176, Num 4, pp 2029-2038, issn 0002-9440, 10 p.Article

The Significance of EphB4 and EphrinB2 Expression and Survival in Head and Neck Squamous Cell CarcinomaYAVROUIAN, Eric J; SINHA, Uttam K; RICE, Dale H et al.Archives of otolaryngology, head & neck surgery. 2008, Vol 134, Num 9, pp 985-991, issn 0886-4470, 7 p.Article

Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loopsMASOOD, Rizwan; KUNDRA, Ajay; ZHU, Sutao et al.International journal of cancer. 2003, Vol 104, Num 5, pp 603-610, issn 0020-7136, 8 p.Article

A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcomaBERNSTEIN, Zale P; CHANAN-KHAN, Asher; MILLER, Kena C et al.Cancer. 2002, Vol 95, Num 12, pp 2555-2561, issn 0008-543X, 7 p.Article

Kaposi sarcoma is a therapeutic target for vitamin D₃ receptor agonistMASOOD, Rizwan; NAGPAL, Sunil; TONG ZHENG et al.Blood. 2000, Vol 96, Num 9, pp 3188-3194, issn 0006-4971Article

Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer ProgressionRAM KUMAR, S; SCEHNET, Jeffrey S; BEART, Robert W et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3736-3745, issn 0008-5472, 10 p.Article

The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockadeSCEHNET, Jeffrey S; LEY, Eric J; KRASNOPEROV, Valery et al.Blood. 2009, Vol 113, Num 1, pp 254-263, issn 0006-4971, 10 p.Article

EphB4 provides survival advantage to squamous cell carcinoma of the head and neckMASOOD, Rizwan; KUMAR, S. Ram; SCHÖNTHAL, Axel H et al.International journal of cancer. 2006, Vol 119, Num 6, pp 1236-1248, issn 0020-7136, 13 p.Article

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancerHOTZ, Hubert G; HINES, O. Joe; MASOOD, Rizwan et al.Surgery. 2005, Vol 137, Num 2, pp 192-199, issn 0039-6060, 8 p.Article

Multidrug resistance (MDR-1) expression in aids-related lymphomasTULPULE, Anil; SHERROD, Andy; DHARMAPALA, Dharshika et al.Leukemia research. 2002, Vol 26, Num 2, pp 121-127, issn 0145-2126Article

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumorsMASOOD, Rizwan; JIE CAI; TONG ZHENG et al.Blood. 2001, Vol 98, Num 6, pp 1904-1913, issn 0006-4971Article

Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcomaREN LIU; MING GONG; XIUQING LI et al.Blood. 2010, Vol 116, Num 2, pp 297-305, issn 0006-4971, 9 p.Article

Expression of EphB4 in head and neck squamous cell carcinomaSINHA, Uttam K; KUNDRA, Ajay; SCALIA, Pierluigi et al.Ear, nose & throat journal. 2003, Vol 82, Num 11, pp 866-870, issn 0145-5613, 5 p., 887 [4 p.]Article

Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryosTRINDADE, Alexandre; KUMAR, S. Ram; SCEHNET, Jeffrey S et al.Blood. 2008, Vol 112, Num 5, pp 1720-1729, issn 0006-4971, 10 p.Article

Phase I study of antisense oligonucleotide against vascular endothelial growth factor : Decrease in plasma vascular endothelial growth factor with potential clinical efficacyLEVINE, Alexandra M; TULPULE, Anil; GILL, Parkash S et al.Journal of clinical oncology. 2006, Vol 24, Num 11, pp 1712-1719, issn 0732-183X, 8 p.Article

Receptor tyrosine kinase EphB4 is a survival factor in breast cancerRAM KUMAR, S; SINGH, Jasbir; WEAVER, Fred A et al.The American journal of pathology. 2006, Vol 169, Num 1, pp 279-293, issn 0002-9440, 15 p.Article

Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancerGUANGBIN XIA; KUMAR, S. Ram; STEIN, John P et al.The Journal of urology. 2006, Vol 175, Num 4, pp 1245-1252, issn 0022-5347, 8 p.Conference Paper

EphB4 expression and biological significance in prostate cancerGUANGBIN XIA; RAM KUMAR, S; DANESHMAND, Siamak et al.Cancer research (Baltimore). 2005, Vol 65, Num 11, pp 4623-4632, issn 0008-5472, 10 p.Article

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcomaTULPULE, Anil; GROOPMAN, Jerome; GILL, Parkash S et al.Cancer. 2002, Vol 95, Num 1, pp 147-154, issn 0008-543XArticle

Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcomaMASOOD, Rizwan; JIE CAI; TULPULE, Anil et al.Clinical cancer research. 2001, Vol 7, Num 9, pp 2693-2702, issn 1078-0432Article